CD52 Antibody (4C8) [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-11701JF646
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Flow Cytometry
Label
Janelia Fluor 646
Antibody Source
Monoclonal Mouse IgG3 Clone # 4C8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for CD52 Antibody (4C8) [Janelia Fluor® 646]
Immunogen
Human lymphocytes
Specificity
The mouse monoclonal antibody 4C8 recognizes CD52, a GPI-anchored glycopeptide expressed on the surface of lymphocytes, macrophages, epithelial cells of male reproductive tract, and mature sperms.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG3
Applications for CD52 Antibody (4C8) [Janelia Fluor® 646]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD52
Alternate Names
CAMPATH-1, CD52, CDw52, He5, HEL-S-171mP
Gene Symbol
CD52
Additional CD52 Products
Product Documents for CD52 Antibody (4C8) [Janelia Fluor® 646]
Product Specific Notices for CD52 Antibody (4C8) [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...